Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

KEBRIAEI, PARTOW

One or more keywords matched the following items that are connected to KEBRIAEI, PARTOW

Item Type	Name
Academic Article	piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.
Concept	Receptors, Antigen
Concept	Receptors, Antigen, T-Cell
Concept	T-Cell Antigen Receptor Specificity
Academic Article	CARs in chronic lymphocytic leukemia -- ready to drive.
Academic Article	Sleeping beauty system to redirect T-cell specificity for human applications.
Academic Article	A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.
Academic Article	Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.
Academic Article	A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.
Academic Article	Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood.
Academic Article	A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.
Academic Article	Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunity.
Academic Article	Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells.
Academic Article	Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective.
Academic Article	Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells.
Academic Article	Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
Academic Article	Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy.
Academic Article	Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.
Academic Article	Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.
Academic Article	Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.
Academic Article	Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.
Academic Article	Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy.
Academic Article	Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Academic Article	Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT).
Academic Article	Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.
Academic Article	Chimeric antigen receptor T-cell therapy toxicities.
Academic Article	Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
Academic Article	Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy.
Academic Article	Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.
Academic Article	Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma.
Academic Article	Patient-Reported Outcomes for Cancer Patients with Hematological Malignancies Undergoing Chimeric Antigen Receptor T Cell Therapy: A Systematic Review.
Academic Article	Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.
Academic Article	Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma.
Academic Article	Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
Academic Article	Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Academic Article	Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies.
Academic Article	Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead.
Academic Article	Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
Academic Article	Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report.
Academic Article	Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.

Search Criteria

Receptors Antigen